Amphastar Pharmaceuticals, Inc. (AMPH)

NMS – Real Time Price. Currency in USD

19.85

-0.57 (-2.79%)

Market open: Aug 12, 2026, 11:29 AM EDT

20.42

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

07.08.2026

Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2026 Earnings Call Transcript

07.08.2026

Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Amphastar (AMPH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

07.08.2026

Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Top Estimates

Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $0.85 per share a year ago.

06.08.2026

Amphastar Pharmaceuticals Q2 Earnings Call Highlights

Amphastar Pharmaceuticals NASDAQ: AMPH reported second-quarter 2026 revenue growth, supported by recently launched products including ipratropium bromide inhalation, while management said it is addressing an FDA warning letter at its IMS subsidiary and continuing investments in its pipeline and U.S. manufacturing operations.

06.08.2026

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026

Net revenues of $183.9 million for the three months ended June 30, 2026 GAAP net income of $30.3 million, or $0.67 per share, for the second quarter Adjusted non-GAAP net income of $40.8 million, or $0.91 per share, for the second quarter Company to hold a conference call today at 2:00 p.m. Pacific Time RANCHO CUCAMONGA, Calif.

Videos

No Data

There is no data to display

Press releases

06.08.2026

Amphastar Pharmaceuticals, Inc. (AMPH)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2026 Earnings Call Transcript

Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics

Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Top Estimates

Amphastar Pharmaceuticals Q2 Earnings Call Highlights

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026

Videos

No Data

Press releases

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026

Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2026 Earnings Call Transcript

Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics

Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Top Estimates

Amphastar Pharmaceuticals Q2 Earnings Call Highlights

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026

Videos

No Data

Press releases

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026

Search stocks

Amphastar Pharmaceuticals, Inc. (AMPH)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2026 Earnings Call Transcript

Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics

Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Top Estimates

Amphastar Pharmaceuticals Q2 Earnings Call Highlights

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026

Videos

No Data

Press releases

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026

Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2026 Earnings Call Transcript

Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics

Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Top Estimates

Amphastar Pharmaceuticals Q2 Earnings Call Highlights

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026

Videos

No Data

Press releases

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026